Roundhill GLP-1 and Weight Loss ETF

Healthcare

Scoring 2 Million Prescriptions, Novo’s GLP-1 Pill Crushes Expectations

Photo via Michael Siluk/UCG/Universal Images Group/Newscom

The pill era has ushered in a Wild-West-style land-grab for GLP-1 market share but the horizon seems to keep expanding.

2 min read

Photo by Clay Banks via Unsplash

ETF Upside

Weight-Loss Drug ETFs Generate Skinnier Returns Than Expected

ETFs tracking the performance of weight-loss drugs have largely underperformed since launching in late 2023.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.